A prospective surveillance for chemotherapy-induced nausea and vomiting
Not Applicable
- Conditions
- malignant tumor
- Registration Number
- JPRN-UMIN000006456
- Lead Sponsor
- Department of Pharmaceutical Services, Hiroshima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient has any illness (e.g. central nervous system tumors, gastrointestinal obstruction, active peptic ulcer, brain metastasis) caused nausea or vomiting except for chemotherapy-induced nausea and vomiting 2) Patient is judged that it is unsuitable as a study patient by investigator (e.g. patient cannot complete study diary)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete Response (no emesis and no rescue therapy) in overall phase (1 to 7 days)
- Secondary Outcome Measures
Name Time Method 1) Complete Response in acute (day 1) and delayed (2 to 7 days) phase 2) Control rate of nausea/vomiting 3) dietary intake 4) Incidence of constipation 5) Degree of satisfaction to treatment of nausea and vomiting